Podcasts about advancing

In this episode of Parenting Is a Joke, comedian Emily Walsh talks to Ophira Eisenberg about becoming a parent later in life and being labeled “advanced maternal age” by New York doctors while taking “nightly little baby aspirin” she was told “sometimes works” for reasons no one could explain. She describes meeting her tiny five-pound newborn who arrived a month early with “newborn fuzz” on her ears and back and a full head of hair that proved her pregnancy heartburn was accurate karma for marrying a very “hairy man.” Parenting for the first time at 40 means learning everything on the fly — sometimes quoting TikToks as if they were books — while hoarding three different “booger-sucking robots,” including a hospital-grade model she gleefully uses every morning. She shares postpartum rage (“Don't kill your husband” turned out to be wise advice), frustration with breastfeeding (“barbaric,” she says), and the absurdity of pumping in Times Square between comedy sets because the manager can't comprehend her need to schedule pumping. A broken ankle took away her baby-calming outdoor walks, she hasn't made a “mom friend” yet, and her social circle is still figuring out she's “not dead,” even as she continues podcasting, stand-up, and raising a baby who dressed as Jeff Goldblum from Jurassic Park with her bassinet converted into the Jeep and her husband in an inflatable T-Rex suit.

“What does it actually mean to understand the brain?”Dr. Kendrick Kay is a computational neuroscientist and neuroimaging expert at the University of Minnesota's Center for Magnetic Resonance Research, where he is an Associate Professor in the Department of Radiology. With training spanning philosophy and neuroscience, from a bachelor's degree in philosophy at Harvard University to a PhD in neuroscience from UC Berkeley, Dr. Kay's work bridges deep theoretical questions with cutting-edge neuroimaging methods.In this conversation, Peter Bandettini and Kendrick Kay explore the evolving landscape of neuroscience at the intersection of fMRI, philosophy, and artificial intelligence. They reflect on the limits of current neuroimaging methodologies, what fMRI can and cannot tell us about brain mechanisms, and why creativity and human judgment remain central to scientific progress. The discussion also dives into Dr. Kay's landmark contributions to fMRI decoding and the Natural Scenes Dataset, a high-resolution resource that has become foundational for computational neuroscience and neuro AI research.Along the way, they examine deep sampling in neuroimaging, individual variability in brain data, and the challenges of separating neural signals from hemodynamic effects. Framed by broader questions about understanding benchmarking progress, and the growing role of LLM's in neuroscience, this wide-ranging conversation offers a thoughtful look at where the field has been and where it may be headed.We hope you enjoy this episode!Chapters:00:00 - Introduction to Kendrick Kay and His Work04:51 - Philosophy's Influence on Neuroscience17:17 - How Far Will fMRI Take Us?23:27 - Understanding Attention in Neuroscience30:00 - Science as a Process34:17 - The Role of Large Language Models (LLMs) in Scientific Progress38:29 - Why Humans Should Stay in the Equation40:30 - Creativity vs. AI in Scientific Research54:48 - Dr. Kay's Natural Scenes Dataset (NSD)01:00:27 - Deep Sampling: Considerations and Implications01:08:00 - Accounting for biological variation in Brain Scans: Differences and Similarities01:13:00 - Separating Hemodynamic Effects from Neural Effects01:16:00 - Areas of Hope and Progress in the field01:21:00 - How Should We Benchmark Progress?01:22:59 - Advice for Aspiring ScientistsWorks mentioned:54:48 -  https://www.nature.com/articles/s41593-021-00962-x54:50 - https://www.sciencedirect.com/science/article/pii/S0166223624001838?via%3DihubEpisode producers:Xuqian Michelle Li, Naga Thovinakere

John Noonan, Organic Advisor, Teagasc, joined Cathal Somers on the latest podcast version of the Signpost Series to discuss ‘Beyond the Farm Gate: The Learnings from Farmer Networks in Advancing Organic Farming Innovation in Europe'. A questions and answers session took place at the end of the webinar which was facilitated by Teagasc's Elaine Leavy. To register for future webinars visit:https://www.teagasc.ie/corporate-events/sustainable-agriculture-webinars/                        For more podcasts from the Signpost Series go to: https://www.teagasc.ie/signpostpodcast/ 

This headline somehow feels both shocking and completely unsurprising.The McKinsey and Lean In Women in the Workplace study is out, and the takeaway is bleak. Fewer companies care about advancing women. Even fewer care about advancing women of color. And somehow, we are now talking about an “ambition gap” like women just collectively woke up and decided to want less.Let's be clear. Women are still paid less. Still underrepresented in the rooms that matter. Still doing most of the work at home. Still being asked to show up like nothing else changed after Covid, after MeToo, after the great return to office squeeze.On this episode of Net Net, we talk about why this moment at work feels so brittle. Why job security feels fake. Why trust in the promise of work is eroding. And why more women are quietly asking themselves what all this effort is actually for.This is not about one group winning and another losing. That zero-sum framing is part of the problem. The real work is opening the aperture. More voices. More paths. More people being given a real shot, and actually being supported when they take it.If you work with people, lead people, or care about what work is turning into right now, this one is worth your time.This is WORK Net/Net. Get full access to WORK at erikaayersbadan.substack.com/subscribe

Interview with Alan Carter, President & CEO of Cabral Gold Inc.Our previous interview: https://www.cruxinvestor.com/posts/cabral-gold-tsxvcbr-pitch-perfect-november-2025-8486Recording date: 10th December 2025Cabral Gold Inc. (TSXV:CBR) has secured $45 million US in gold loan financing to construct its first mine at the Cuiú Cuiú project in northern Brazil, with commercial production targeted for Q4 2026. The financing structure avoids equity dilution during the critical construction phase, preserving shareholder value whilst enabling the company's transition from explorer to cash-generating producer.Construction activities have accelerated substantially with 143 personnel on site, 50 pieces of heavy equipment operational, and major foundation concrete pours scheduled by year-end. President and CEO Alan Carter confirmed: "We recently raised $45 million US through a gold loan. Projects in construction. We should be producing gold in the fourth quarter of 2026," noting "there was no equity raise as part of that, which I think surprised a lot of people."The project benefits from unusually deep oxide weathering averaging 60 metres – a geological characteristic Carter describes as "quite unusual from most gold deposits around the world." This creates substantial free-digging material processable through simple metallurgical circuits without conventional crushing and grinding infrastructure, enabling low-capital initial operations.Cabral's strategic differentiation centres on its two-stage development approach designed to eliminate serial equity dilution. The initial 1,500 tonnes per day oxide operation generates internal cash flow to fund aggressive exploration of much larger hard rock resources beneath the weathered zone, transforming the company from market-dependent explorer into self-funding entity. Carter articulated the rationale: "We think that the best way to fund all that work that needs to be done is not by continually diluting the capital structure and doing private placement after private placement and ending up with a massive number of shares issued and outstanding."Unlike typical developers focused solely on construction execution, Cabral maintains three drill rigs and 80 exploration personnel operating concurrently with mine building. Recent drone magnetic surveys confirmed clear structural continuity over 2 kilometres between the Central deposit and PDM discovery, with reconnaissance drilling validating gold intersections along the newly identified trend. Carter characterised this as "tremendously exciting," substantially expanding prospective ground between known deposits.Management describes Cuiú Cuiú as a district-scale gold system with four new discoveries since the 2022 resource estimate and 50 additional peripheral targets with identified gold. Carter positioned the oxide operation within this broader context: "The bigger prize at Cuiú Cuiú is the definition of this very, very large gold district that clearly contains multiple deposits."The permitting pathway utilises Brazilian trial mining licences for initial operations with full mining licence approval for 3,000 tonnes per day expansion anticipated January 2026. Recent public consultations demonstrated no community opposition, de-risking regulatory progression. The full permit isn't operationally required until mid-2027, providing comfortable scheduling buffer.Project execution benefits from experienced Brazilian mining personnel including Luis Salaro, who has built multiple coal mines in Brazil, alongside Ausenco engineering support and what Carter describes as "a very impressive group of consultants."Cabral's investment proposition combines near-term production catalyst, non-dilutive financing preserving equity value, and district-scale exploration potential funded through internal cash generation. The parallel execution of construction and exploration positions the company to enter production with an expanded resource base rather than simply a built mine processing fixed inventory, creating multiple value drivers as Cabral transitions from explorer to cash-generating producer with growth optionality in a strong gold price environment.View Cabral Gold's company profile:https://www.cruxinvestor.com/companies/cabral-goldSign up for Crux Investor: https://cruxinvestor.com

Kelly Perry, Senior Digital Marketing Manager at Stratus Live, joins the show to discuss how enterprise nonprofits can modernize donor engagement and streamline complex fundraising operations. She explains how Stratus Live's integrated nonprofit cloud platform helps teams consolidate fragmented systems, improve donor journeys, and scale impact with AI-driven recommendations. Kelly also shares insights on ethical AI adoption, lead qualification challenges, and the growing importance of generative engine optimization as organizations shift their discovery behavior toward LLMs. This episode gives marketers and nonprofit leaders practical guidance on using technology, content strategy, and data to strengthen relationships, save time, and drive meaningful growth.

Join us for the keynote address from the 2025 Kaldor Centre Conference, 'Building bridges: Advancing refugee protection in a divided world' held on 23 October 2025 at UNSW Sydney. Speakers Daniel Ghezelbash, Professor of Law & Director, Kaldor Centre for International Refugee Law, UNSW Sydney Mohammed Naeem, Senior Director for Advocacy Strategy, Refugees International Timestamp 00:00 Opening remarks, Daniel Ghezelbash, Kaldor Centre for International Refugee Law, 13:40 Daniel Ghezelbash introduces Mohammed Naeem 15:19 Keynote address, Mohammed Naeem, Refugees International 32:48 Audience Q&A with Mohammed Naeem and Daniel Ghezelbash in conversation during question time Why Listen *Understand why the Refugee Convention remains vital and why implementation, not the law itself, is failing. *Learn how polarization and misinformation threaten refugee protection and what works to rebuild trust. *Discover why imagination and community-driven solutions are key to designing inclusive, lasting systems. *Hear a powerful call to elevate refugee leadership and show that caring isn't just moral, it works. Transcripts Daniel Ghezelbash opening remarks: https://www.unsw.edu.au/news/2025/11/the-refugee-convention-is-under-threat--but-it-is-not-the-proble Mohammed Naeem keynote address: https://www.unsw.edu.au/news/2025/11/mohammed-naeem-gives-keynote-address-at-the-2025-kaldor-centre-c

Read the full show notes: https://www.draimee.org/from-patient-connection-to-policy-change-advancing-fertility-amp-ivf-care-in-the-u-s-with-guest-kaylen-silverberg-md In this episode of The Egg Whisperer Show, I'm thrilled to welcome Dr. Kaylen Silverberg, medical director and managing partner at Texas Fertility Center, co-founder of Ovation Fertility, and a leading advocate for patients navigating IVF and reproductive medicine in the United States. Dr. Silverberg shares his journey from aspiring heart surgeon to passionate fertility specialist, and how his deep connections with patients inspired him to bridge the gap between clinical care and national policy change. Watch this episode on YouTube. In this episode, we cover: Dr. Silverberg's personal journey from heart surgery to reproductive medicine The power of patient stories in influencing national policy and lawmakers The mission and current legislative efforts of Americans for IVF Recent changes and proposals to make fertility medications and IVF more affordable The impact of bipartisan advocacy and the importance of building relationships with representatives Advances in endometriosis research and its effect on fertility The promise and limitations of genetic testing in IVF How listeners can get involved in advocacy and make their voices heard Resources: Texas Fertility Center: https://www.txfertility.com Americans for IVF: https://americansforivf.org Resolve: The National Infertility Association: https://resolve.org American Society for Reproductive Medicine: https://asrm.org Dr. Silverberg's Instagram: https://www.instagram.com/lets_talk_about_fertility/ Subscribe to The Egg Whisperer Show on YouTube and Spotify Join Dr. Aimee's IVF Class at The Egg Whisperer School Learn About Dr. Aimee's Fertility Essentials

This edWeb podcast is sponsored by Vista.The webinar recording can be accessed here.District administrators and supervisors are uniquely positioned to drive systemwide change that supports equitable literacy outcomes for multilingual learners. This edWeb podcast discussion brings together perspectives from research, policy, district leadership, and instructional approaches.The presenters share:Concrete strategies for systematizing curriculum, instructional models, and teacher supportApproaches to sustaining professional development and progress monitoringGuidance on family engagement and adapting to various district culturesReal-world examples of laying a research-backed foundation for multilingual learner successAll registrants receive downloadable checklists, project templates, and a curated set of actionable resources to support ongoing success.This edWeb podcast is of interest to K-12 school and district leaders.VistaHighest-quality integrated print and digital solutions that meet the needs of all language learnersDisclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Learn more about viewing live edWeb presentations and on-demand recordings, earning CE certificates, and using accessibility features.

In this week's episode of the LiberatED Podcast, Kerry McDonald interviews Ali Ghaffari, founder of Divine Mercy Academy, a K–8 classical Catholic school in Pasadena, Maryland, and now Executive Director of the St. John Henry Newman Institute, an organization dedicated to accelerating the renewal of Catholic education worldwide. Ali's path to school founding is anything but ordinary. After graduating from Colby College, he spent 20 years in the U.S. Navy as an F/A-18 fighter pilot before teaching leadership and ethics at the U.S. Naval Academy. Raised without religious belief, Ali experienced a dramatic conversion sparked by reading the Great Books—an encounter that convinced him of the importance of deep intellectual and moral formation. When he couldn't find a classical Catholic school nearby for his children, he joined with other families to start one. *** Sign up for Kerry's free, weekly email newsletter on education trends at edentrepreneur.org. Kerry's latest book, Joyful Learning: How to Find Freedom, Happiness, and Success Beyond Conventional Schooling, is available now wherever books are sold!

How does strong infection prevention leadership reshape long-term care? In this episode, host Lerenza Howard sits down with Tiberius Stanescu, RN, CIC, LTC-CIP, to explore how certification, regulation, and national standards are elevating care for older adults. Hear how Canada's approach is informing global best practices—and what long-term care teams around the world can learn from it. Hosted by: Lerenza L. Howard, MHA, CIC, LSSGB About our Guest: Tiberius Stanescu, RN, CIC, LTC-CIP Tiberius Stanescu is a globally educated Registered Nurse with diverse clinical background spanning multiple medical specialties. He began his nursing career in 2000, specializing in operating room procedures and plastic and reconstructive surgery, before discovering a deep passion for long-term care. His leadership in this field led him to serve as Assistant Director of Care and director of nursing role, where he furthered his expertise in infection prevention and wound management. In 2015, Tiberius joined the Infection Prevention and Control (IPAC) team at Scarborough Health Network and earned his Certification in Infection Control (CIC) in 2018. During the COVID-19 pandemic, he played a pivotal role in the IPAC hub, reaffirming his commitment to long-term care. Tiberius has contributed significantly to the field through his involvement with the Certification Board of Infection Control and Epidemiology (CBIC), helping to develop the Long-Term Care Certification in Infection Prevention (LTC-CIP) exam. He serves as Chair of IPAC Canada's Long-Term Care Interest Group, underscoring his dedication to advancing infection prevention standards and enhancing care quality in long-term care settings.

In this podcast, we spoke with Troy Ostreng, Senior Product Manager and David Burdge, Director of Cell and Gene Therapy at CPC about the development of the MicroCNX® aseptic micro-connectors and how they're helping biopharma teams streamline closed-system operations for cell and gene therapies. What unfolded was a detailed and forward-looking conversation that touched on CPC's 47-year legacy, the technical demands of advanced therapies, and the company's plans to drive the future of automation and sterility in manufacturing. A Legacy That Positioned CPC for Today's Advanced Therapy Boom When asked how CPC's long history in biologics and hospital environments prepared the company for today's cell and gene therapy landscape, David took us back to CPC's roots. “CPC was founded in 1978, so that's 47 years of innovation within connection technologies,” he said. “The first biologic was released in 1982, synthetic insulin, and we were there supporting the industry with open-format connectors on single-use bags.” From the early development of biologics through the shift to single-use and the rise of stainless-steel/single-use hybrid systems, CPC continuously evolved its connection technologies. They launched steam-through connectors as bioprocessing grew more complex, released their first aseptic connector in 2009, and introduced their first connector specifically targeted for the cell and gene therapy market in 2017. David explained how that history matters today: “Biologics has about a 35-year head start on advanced therapies. So the question becomes, what lessons can we transfer from biologics to cell and gene therapy as that industry grows at three to four times the rate biologics did in its first decade?” That perspective, combining biological manufacturing experience with the needs of new therapy modalities, forms the foundation for CPC's MicroCNX platform. MicroCNX: The First Aseptic Connector Built for Small-Format Tubing As cell and gene therapy developers began scaling up manufacturing, they quickly discovered a problem: the connectors used for biologics were not designed for small-volume, patient-specific therapies. Troy described it plainly: “Several years ago, we started hearing rumblings that current connectors weren't meeting what cell and gene therapy required.” CPC responded with a deep Voice of Customer (VOC) initiative, interviewing process engineers, operators, manufacturing leaders, and platform developers. Over and over, the same needs emerged. Operators wanted something simple. “Ease of use was the number one requirement,” Troy said. “Operators needed a product that was easy to use so they could make sterile connections in a short amount of time.” Processes demanded robustness. “Customers needed a connection they could trust—no contamination, no failures, no weak spots in the connection process,” he added. Small-volume precise applications required connectors actually designed for them. With autologous therapies, he noted, “We aren't talking about 1,000 liters; we're talking about 250 milliliters. And if there's a mishap, that could mean the difference between life and death for a patient.” All of this laid the groundwork for MicroCNX, which became the first aseptic connector engineered for small-format tubing. The “Pinch-Click-Pull” Process: Sterility Meets Speed One of the standout features of MicroCNX is its elegantly simple pinch-click-pull operation. Troy explained how simplicity came directly from user feedback. “As operators walked us through their pain points, what they needed was clear: a connector they could learn immediately. So MicroCNX has a three-step process—pinch, click, pull. You can literally do it as fast as I say it.” He continued,“Once someone does it one time, they're basically an expert. That ease of use dramatically reduces operator error.” For an industry where operator variability remains one of the biggest sources of risk and batch loss, eliminating complexity is critical. Cryogenic Challenges Call for Cryo-Rated Solutions As the conversation shifted to cryopreservation, a critical component of cell therapy manufacturing,Troy introduced the MicroCNX® ULT and MicroCNX® Nano variants. “These were really developed because therapies were being frozen to –150°C, even –190°C. You need a connector that can be frozen to those temperatures, thawed, and still be as robust as it was before.” The ULT and Nano were engineered with: Low-profile geometries to fit inside freezing cassettes Specialized materials to withstand thermal stress Chemical compatibility with DMSO and other cryoprotectants Enhanced durability to survive impacts while frozen Troy emphasized how critical it was to get the materials right: “We searched extensively for a material that could handle those harsh chemicals and temperatures. What we landed on was PPSU—polyphenylsulfone. It's chemically sound, and it's incredibly impact-resistant at very low temperatures.” CPC built these connectors because customers repeatedly told them: existing solutions were cracking, leaking, or becoming brittle. MicroCNX was engineered to overcome all of that. True Closed Systems vs. Functionally Closed Systems: Why the Difference Matters A substantial part of the conversation focused on the differences between closed, functionally closed, and open systems—distinctions that are often overlooked but critically important. Troy broke down the differences clearly: “An open system is exposed at some point. A functionally closed system is inherently open but gets closed temporarily to let fluid transfer. In comparison, a closed system is never open at any point.” Examples of functionally closed systems include: Biosafety cabinets (BSCs) Luer-based connections Closed system transfer devices These approaches require: Sanitization Careful environmental controls Operator expertise And, as Troy noted, “a mishap in one of these can mean losing a very valuable therapy.” CPC's sterile connectors—including MicroCNX minimize these risks: “Our connectors allow the system to remain closed 100% of the time. That greatly reduces contamination risk.” This distinction isn't merely academic—it has direct regulatory implications as well. David added,“In Annex 1, they refer to intrinsically sterile connection devices—like sterile connectors and tube welders—that allow operations normally requiring Grade A or B to occur in a Grade C or D environment.” That ability to operate safely in lower-grade spaces is increasingly critical as the industry tries to overcome facility and labor bottlenecks. Why Teams Are Moving Away from Tube Welding Tube welding has been part of bioprocessing for decades, but David explained why its era may be ending for CGT. “Tube welding was born out of the blood banking industry when no other solution existed. But sterile connectors don't require capital investment. They're faster. They eliminate issues like tubing alignment or pinhole leaks. They're simply more reliable.” As biologics manufacturers have already done, CGT teams are now transitioning toward connectors like MicroCNX® that provide sterile, consistent, low-burden operations. The MicroCNX® Luer Variant: Supporting Transitional Workflows Not all workflows are ready to move away from luer-based devices. That's where the MicroCNX Luer variant fits in. Troy described how it works.“You connect a syringe or bag with a luer inside the BSC, but then because the MicroCNX® connector itself is sterile, you can take it outside the hood and make a sterile connection elsewhere.” This capability bridges legacy workflows and fully closed systems—critical during process development, technology transfer, or when working with specific devices. Co-Development: The Heart of CPC's Innovation Process As the conversation returned to CPC's broader philosophy, David highlighted how important customer collaboration is. “It's all about the customer for CPC,” he said. “We start with Voice of Customer. Our business and applications managers are out in the field understanding real applications and guiding them to the right products.” This feedback fuels CPC's two major development tracks: Catalog product development (platforms like MicroCNX) Custom-engineered solutions for unique applications David added: “We maintain a full new product introduction roadmap. Some products will be released broadly. Others will be developed specifically for one customer. But both are driven by real application requirements.” This process ensures CPC's products evolve in lockstep with the needs of advanced therapy teams. Looking Ahead: Designing Connectors for Robotics and Automation Toward the end of the conversation, David turned to one of CPC's biggest focus areas: the future of automation. “The ultimate customer in this industry is the patient,” he said. “And right now we face barriers—capacity, speed, accessibility, cost. Process automation can significantly reduce those barriers.” Automation requires connectors designed not just for human hands but for robotics: Predictable geometries Features optimized for machine vision Forces and actuation steps compatible with robotic grippers Designs intended for automated loading and unloading David summarized CPC's future direction: “We're taking a fresh look at our connectors, reimagining them as something designed for robotic manipulation. It's a high priority for us.” Troy echoed the sentiment: “Our connectors are awesomely designed for humans. But automation is coming, and we're focused on the features robots need.” A Future Built on Innovation and Patient Impact The interview closed with both guests reflecting on CPC's mission. “We're incredibly passionate about innovation and meeting the needs of our customers through thoughtful product development,” Troy said.

Please visit answersincme.com/860/99534447-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. In this activity, experts in dermatology and rheumatology discuss the use of TYK2 inhibitors in the treatment of patients with psoriatic disease, including PsA. Upon completion of this activity, participants should be better able to: Discuss the rationale for using novel TYK2 inhibitors in the treatment of patients with psoriatic disease, including PsA; Review the latest evidence on the use of novel TYK2 inhibitors in patients with psoriatic disease, including PsA; and Outline multidisciplinary strategies for the optimal integration of novel TYK2 inhibitors into treatment plans for patients with psoriatic disease, including PsA.

Please visit answersincme.com/860/99534447-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. In this activity, experts in dermatology and rheumatology discuss the use of TYK2 inhibitors in the treatment of patients with psoriatic disease, including PsA. Upon completion of this activity, participants should be better able to: Discuss the rationale for using novel TYK2 inhibitors in the treatment of patients with psoriatic disease, including PsA; Review the latest evidence on the use of novel TYK2 inhibitors in patients with psoriatic disease, including PsA; and Outline multidisciplinary strategies for the optimal integration of novel TYK2 inhibitors into treatment plans for patients with psoriatic disease, including PsA.

Today, Pastor Jack teaches that our advancement is in God's timing. Like David, our focus is to be ready for service in whatever role we find ourselves in. To live a Christ centered life is to submit to His agenda, not rushing ahead or comparing ourselves to others.

Tudor Gold CEO Joe Ovsenek joins Mining Stock Daily to outline the company's priorities for advancing the Goldstorm deposit at Treaty Creek. Ovsenek discusses the upcoming resource update, ongoing metallurgy work, and plans to pursue a mid-year PEA. He also details the strategy behind pursuing an underground exploration ramp, how new zones could add meaningful ounces, and why improved access may accelerate drilling year-round. The conversation closes with insights on funding, timelines, and what investors often overlook about Treaty Creek's potential to become a standalone mine.

This edWeb podcast is sponsored by UnboundEd.The edLeader Panel recording can be accessed here.While the free GLEAM® instruction framework—grade-level, engaging, affirming, and meaningful—offers guiding principles and strategies to get to the art of teaching, its not-so-secret power lies in its ability to inform systems. This edWeb podcast invites listeners to look beyond tools and resources to consider how GLEAM shapes mindsets, planning, and leadership.Drawing on years of coaching and consulting across schools and districts, we push on our hypothesis to help you refine your theory of action—and help you adjust your thinking about improvement to align with GLEAM. By the end of this session, listeners are able to:Use GLEAM to surface mindset work and shift adult culture toward student-centered, effective instructionApply GLEAM as a lens for examining and strengthening organizational and instructional operating frameworksLeverage GLEAM to evaluate and align tools, resources, and practices that drive meaningful teaching and learningThis edWeb podcast is of interest to K-12 school and district leaders.UnboundEdWe partner with educators to improve instruction so all kids thrive.Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Learn more about viewing live edWeb presentations and on-demand recordings, earning CE certificates, and using accessibility features.

Advancing past the ancient Elven stonework, the Party encounters guardians from the Cinder Claw Cult.Special Thanks:Theme Music - "Together We Rise" by Wind Rose (used with permission) Sound Effects and additional music courtesy of Table Top Audio, Ovani Sound and Monument StudiosDice for the cast of Wayfinder Legends provided by Esty Way Gaming.Wayfinder Legends is a Red Dirt RPG, LLC production.JOIN THE PARTY! CAST:Special Guest: Jessica as Renali, a mysterious druid from the Mwangi ExpanseJeremy - Boddy, a Hobgoblin seeking a new purposeHal - Plame, a charismatic and entertaining, young goblinEmily - Inara, a confident and hot-headed, young Kellish womanBrook - Fawin, an Aiuvarin (half-elven) born into privilegeStacy - Pathfinder 2e Gamemaster

Masterpiece Audiobooks: Collection of Chinese Classic Novels

Masterpiece Audiobooks: Collection of Chinese Classic Novels

Today, Pastor Jack asks the question, “are we investing in God's Kingdom or squandering it? Are we devising our own advancement, or are we frustrated with the smaller roles we've been given, as God's larger plan is unfolding?”

From first-generation employee to visionary CEO, Liza Streiff shares how she grew a small training firm into the gold standard for Wall Street exam preparation while reshaping what leadership can look like for women in finance.As the youngest and first female CEO of Knopman Marks, Liza has built her career on purpose, resilience, and a belief in what people can achieve with the right support. She joined the company straight out of college planning to stay only a year, yet quickly connected with the mission of helping students pass high stakes exams that unlock life changing careers. Today she is known for a transformative approach to learning and high performance coaching that helped quadruple the company's size and earned her recognition as Female Executive of the Year at the 2023 Stevie Awards for Women in Business.In our conversation, Liza shares the pivotal moments that shaped her leadership, including stepping into the CEO role just before the pandemic. She describes guiding the company through a swift move to digital learning, a shift that expanded their national reach and strengthened their impact. She also reflects on how her own learning disabilities became an advantage in creating training that blends structure, empathy, and innovation.Liza offers practical insights on leading in fast changing environments, supporting Gen Z professionals, and cultivating entrepreneurial thinkers inside large organizations. She highlights the lasting importance of human connection in education and the mindsets needed to build meaningful careers. We also talk about her work through the Betty Kiernan Foundation, which provides targeted support to women pursuing nursing degrees and families in crisis.This episode is a powerful reminder of what is possible when women lead with clarity, heart, and conviction. Tune in to hear Liza's full story and the lessons she hopes will inspire the next generation of leaders.Chapters

Today, Pastor Jack teaches that David is advancing God's kingdom through his service. And, even though David is anointed, but not yet king, God uses him in a lesser way because of his faithfulness, and willingness to be available and obedient.

In this episode, Dan Collard, Co Founder of Healthcare Plus Solutions Group, discusses the group's recent acquisition focused on nurse leadership development, the importance of human centered leadership, and his upcoming book Genfluence. He also shares insights on the second edition of Rewiring Excellence and how leaders can better support teams in a rapidly evolving health care environment.This episode is sponsored by Healthcare Plus Solutions Group.

Advancing Sustainable Solutions For A Resilient Planet by Capital FM

Send us a textThis 2023 episode of Fanachu featured as guest attorney and veteran Peter J. Santos who discussed issues of Chamoru advancement and achievement both in the islands and abroad. On the episode he shared his own experiences but also those of other Chamorus who have persevered in systems of discrimination and racism to excel in the ranks of the US military, higher education and business. This episode originally premiered on April 5, 2023. This episode was hosted by Michael Lujan Bevacqua. The audio for this episode was produced by Tåsi Chargualaf.Support the show

 This week on the PHP Podcast, Eric and John talk about PhpStorm Plugins, Open-source IntelliJ IDEA, JetBrains AMA, PHP Foundation looking for a Executive Direstor, watch John NOT mention Eric in his latest podcast interview, and more… Links from the show: explain.md · GitHub John Congdon: the PHP Architect – YouTube The PHP Foundation is Seeking a New Executive Director — The PHP Foundation — Supporting, Advancing, and Developing the PHP Language PhpStorm Plugins You Might Not Know | The PhpStorm Blog Open-source IntelliJ IDEA: A Simpler Way to Build and Contribute to the Community | The IntelliJ IDEA Blog Ask Us Anything During JetBrains AMA Week | The JetBrains Blog The PHP Podcast streams the recording of this podcast live, typically every Thursday at 3 PM PT. Come join us and subscribe to our YouTube channel. X: https://x.com/phparch Mastodon: https://phparch.social/@phparch Bluesky: https://bsky.app/profile/phparch.com Discord: https://discord.phparch.com Subscribe to our magazine: https://www.phparch.com/subscribe/ Host: Eric Van Johnson X: @shocm Mastodon: @eric@phparch.social Bluesky: @ericvanjohnson.bsky.social John Congdon X: @johncongdon Mastodon: @john@phparch.social Bluesky: @johncongdon.bsky.social Streams: Youtube Channel Twitch Partner This podcast is made a little better thanks to our partners Displace Infrastructure Management, Simplified Automate Kubernetes deployments across any cloud provider or bare metal with a single command. Deploy, manage, and scale your infrastructure with ease. https://displace.tech/ PHPScore Put Your Technical Debt on Autopay with PHPScore Honeybadger.io Honeybadger helps you deploy with confidence and be your team's DevOps hero by combining error, uptime, and performance monitoring in one simple platform. Check it out at honeybadger.io Music Provided by Epidemic Sound https://www.epidemicsound.com/er helps you deploy with confidence and be your team's DevOps hero by combining error, uptime, and performance monitoring in one simple platform. Check it out at honeybadger.io Epidemic Sound https://www.epidemicsound.com/ The post The PHP Podcast 2025.12.04 appeared first on PHP Architect.

Join Hedi Ben Brahim, CEO of One Biosciences and a leading figure in the French biotechnology ecosystem, in an in-depth conversation with Gary Fowler as they explore how single-cell technologies are transforming precision medicine. Learn how One Biosciences is unlocking new therapeutic targets, expanding to the U.S., and navigating the challenges of scaling an innovation-driven biotech company.Insights You'll Learn:✓ What single-cell analysis enables that traditional drug discovery cannot✓ How One Biosciences identifies new targets for difficult-to-treat diseases✓ Challenges and opportunities in expanding a European biotech to the U.S. market✓ Why computational biology is central to the next wave of precision therapeutics✓ How to build an integrated discovery engine combining wet lab and in-silico innovation✓ Lessons from leading biotech, oncology, and immunotherapy organizations✓ The current biotech landscape — and what founders must prepare for nextWhy This Matters:Single-cell technology is redefining how we understand disease at a molecular level. One Biosciences sits at the forefront of this revolution, combining computational power with multidisciplinary research to accelerate new therapies for complex conditions.Hedi's leadership—across public policy, oncology, immunotherapy, and biotech scaling—offers rare insight into what it takes to bring breakthrough science from Europe to the global stage.Expert Background:• Chief Executive Officer of One Biosciences• Former CEO of Transgene, a leader in immunotherapy and oncology• Veteran of France's Ministry of Economy and Ministry of Health• Held leadership roles across biotech, healthtech, and research institutes• Board member at GeNeuro and Kolibri• Recognized expert in precision medicine, oncology, and biotech innovationAbout One Biosciences:One Biosciences leverages advanced single-cell analysis to power a new wave of precision medicine. Its integrated discovery engine fuses computational biology and multidisciplinary expertise to find therapeutic targets for complex, difficult-to-treat diseases. Supported by Institut Curie and Home Biosciences, it is accelerating breakthroughs in drug discovery.

This episode of Justice Speaks explores advancing community supervision with Cobi Tittle, Director of Tarrant County CSCD and President of NAPE. She discusses leadership, data-driven decision-making, the evolving role of probation officers, technology's promise, and the need to refocus probation on rehabilitation as a vital public-safety strategy. Sponsored by Reconnect.

Dr. Kyle Fulton—the region's only fellowship-trained pediatric craniofacial specialist—shares how Manning Family Children's has built a leading program for children with the most complex facial and skull conditions. He explains the importance of specialized expertise, how early detection shapes care, and the life-changing treatments his team provides for patients and families. Dr. Fulton closes with a heartfelt message on why listener support is essential to sustaining and expanding this critical work.

World Class CME, organizer of the new National Diagnostic Imaging Symposium, announced their World Class CME In-Person Conference event will be held in Disney's Yacht Club Resort Lake Buena Vista, FL on December 7-11, 2025 World Class CME City: Charlotte Address: 6201 Fairview Rd. Website: https://worldclasscme.com/

In this episode of Dana Tech Talks, Dana Moreau speaks with Anastasia Albanese-O'Neill, Vice President of Medical Affairs at Breakthrough T1D, about the critical role clinical trials play in advancing type 1 diabetes care. They explore emerging therapies, growing screening efforts, and practical tools that help clinicians connect patients to research opportunities. Together, they highlight how building a culture of trial participation can accelerate progress toward T1D cures. Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast. Learn more about ADCES and the many benefits of membership at adces.org/join. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

The Catalonian Anti-Doping Laboratory was established in 1985, and this year marks their 40th anniversary of operations. Dr. Rosa Ventura Alemany is Director of the laboratory, which is within the Hospital del Mar Medical Research Institute (IMIM) in Barcelona, Spain. In this episode, she discusses how the laboratory and the field of anti-doping have evolved over the years, some of the lab's major contributions to anti-doping science, and current research projects spanning investigations of the use of sulfate metabolites as markers to detect anabolic steroids, glucocorticoids and how to differentiate between permitted versus prohibited administration, and the analysis of doping agents in dried blood spot (DBS) samples.

Climate risks continue to increase in complexity, underscoring the urgent need to address their impacts through a strong focus on adaptation and resilience. At the same time, innovative insurance products and financing are helping climate and resilience investments become more accessible and viable. Last month's COP30, the United Nations Climate Change Conference, underscored the importance of accelerating adaptation and resilience efforts, given recognition of climate change as a present reality demanding immediate solutions. In this episode of Risk in Context, Marsh's Graeme Riddell, Nick Faull, and Rodrigo Suárez, and Marsh McLennan's Swenja Surminski discuss key takeaways from COP30, focusing on the implications and opportunities for risk managers navigating the complex challenges of climate adaptation and resilience. You can access a transcript of the episode here. Listen to our recent podcast, Unpacking water-related economic risks and solutions. For more insights and insurance and risk management solutions, follow Marsh on LinkedIn and X and visit marsh.com.

In this episode, Dr. Sumana Moole of Merus Gastroenterology & Gut Health LLC,  discusses her path to founding an independent GI practice, the growth of complex procedures in ASCs, and how AI and physician-led models are reshaping patient centered gastroenterology.

In this episode, Joel Vengco discusses Hartford HealthCare's commitment to expanding access, harnessing data, and building consumer centered digital experiences, while sharing how AI, agentic technologies, and workforce evolution will shape the system's future.

In this episode, Dr. Sumana Moole of Merus Gastroenterology & Gut Health LLC,  discusses her path to founding an independent GI practice, the growth of complex procedures in ASCs, and how AI and physician-led models are reshaping patient centered gastroenterology.

Chronic obstructive pulmonary disease (COPD) care is evolving—learn how communication and patient empowerment are transforming treatment. Credit available for this activity expires: 11/28/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/patients-progressing-ai-cdk4-6-inhibitors-biomarkers-2025a1000wtp?ecd=bdc_podcast_libsyn_mscpedu

Drs. Camacho and Lewiecki discuss emerging osteoporosis therapies that are revolutionizing bone health treatment, with promising developments like oral parathyroid hormone medications and dual-action anabolic agents that challenge traditional injection-based approaches. Biosimilars, particularly for denosumab, are expanding patient access by offering highly similar, potentially more affordable alternatives to brand-name drugs, signaling a transformative era in osteoporosis care.

President Trump's Executive Order 14212 established the Make America Healthy Again (MAHA) Commission under the U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. to address the nation's escalating childhood chronic disease crisis The MAHA Commission identified four key drivers of illness — poor diet, chemical exposure, chronic stress, and overmedicalization. It also introduced a coordinated national strategy built on research, systems reform, public awareness, and accountability In a recent report by Dr. Robert Malone, one of RFK Jr.'s appointed vaccine advisers, he explains that Congress must turn MAHA's executive directives into law to ensure the reforms become lasting national policy Malone categorized the MAHA legislative agenda into five areas of reform — addressing food standards, medical accountability, agricultural freedom, agency coordination, and government transparency To show your support, call or write your representatives directly, because real reform starts when your voice reaches the people writing the laws that shape your family's future

In this episode, Joel Vengco discusses Hartford HealthCare's commitment to expanding access, harnessing data, and building consumer centered digital experiences, while sharing how AI, agentic technologies, and workforce evolution will shape the system's future.

Dr. Linda Chu hosts a conversation with Dr. Chiara Bucciarelli-Ducci, Dr. Tim Leiner, and Gwenael Herigault on the latest innovations in cardiac MRI. They discuss how AI-driven workflow automation and helium-free systems are improving access, efficiency, and collaboration between radiologists and cardiologists. The episode also explores how advances in training, technology, and teamwork are enhancing care for cardiovascular patients. Sponsored by Philips Healthcare.

On the latest Vet Blast Podcast presented by dvm360 episode, host Adam Christman, DVM, MBA sits down with Bonnie D. Wright DVM, DACVAA, to explore the cutting edge of multimodal analgesia. Wright dives into the critical need for integrating pharmacologic and non-pharmacologic techniques for optimal pain control. 

Voices is a new mini-series from Humanitarian AI Today. In daily five-minute flashpods we pass the mic to humanitarian experts and technology pioneers, to hear about new projects, events, and perspectives on topics of importance to the humanitarian community. In this flashpod, Radek Wierzbicki, CEO of Unsung Heroes, speaks with Humanitarian AI Today producer Brent Phillips about his team's work connecting startups with humanitarian organizations and Unsung Heroes' Humanity Badge initiative, a platform that builds the reputation of humanitarian and development workers and their organizations. They discuss Unsung Heroes' core interests in advancing digital literacy and entrepreneurship and their work in Tanzania supported by the Polish Minister of Foreign Affairs and the Polish Embassy in Tanzania helping mentor young people interested in launching technology startups. They also discuss Unsung Heroes' work distributing and training people on using computers and AI applications, and their work launching and partnering on technology incubators and accelerators advancing digital entrepreneurship. Substack notes: https://humanitarianaitoday.substack.com/p/radek-wierzbicki-from-unsung-heroes

What if the biggest reason you're not being promoted has nothing to do with office politics, company structure, or how hard you work? In this transformative episode, host Bernadette Boas sits down with Diane Taylor, founder of Glow Leadership and author of Elevate Potential, to expose the surprising internal blocks that silently derail professional advancement.Diane reveals how unconscious habits, emotional blind spots, and unexamined internal patterns dictate how we behave, lead, and ultimately rise—or stall—in our careers. She breaks down why leaders lose trust, how chaos becomes a comfort zone, and why intentional inner work is the true fast track to career success.Whether you're a rising corporate star, a seasoned leader, or someone feeling stuck, this episode gives you the clarity and tools to shift from “Why not me?” to “Watch me.”

Local advertising is one of the most effective methods for brands of all sizes to reach the audiences that matter most, and platforms like Locality's LocalX are becoming industry leaders by enabling advertisers to plan, buy and measure local broadcast and streaming in one intelligent workflow. LocalX was purpose-built for local advertising, and by using real-time insights and unified data, the platform empowers agencies and partners to maximize impact with confidence." At the end of the day, the reason we're targeting local is to drive a better outcome for our brand in a local community or local space," said Zach Mullins, chief strategy officer at Locality, on a special edition of Ad Age's Marketer's Brief podcast. "By creating unification at scale, we can do that much more effectively in local markets." Tune in to hear more about how LocalX works to combat the increasing complexity and fragmentation within local markets, advance the local ad-buying ecosystem, and the future the company sees for the local media market.

This episode discusses the government shutdown including the Democrats' reasons behind it and how it came to a conclusion. It also offers two solutions to prevent a future shutdown.REFERENCES:(1) Episode 11 of the Advancing the Agenda Podcast: "The Filibuster, Cloture Motion, Reconciliation, and the Nuclear Option in the U.S. Senate"(2) The 12 Appropriations Subcommittees from the Website of Congressman Mike Sampson (R-ID):Twelve Appropriations Subcommittees determine discretionary funding for government functions.  Each of these subcommittees produces one bill each year.  Subcommittees include:Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, which oversees funding for the USDA (except the Forest Service) and other agencies;Commerce, Justice, Science, and Related Agencies, which oversees funding for the Department of Commerce, the Department of Justice, NASA, and other agencies;Defense, which oversees funding for the military, the intelligence community, and other national defense related agencies;Energy and Water Development, which oversees funding for the Department of Energy, the U.S. Army Corps of Engineers, and other agencies;Financial Services and General Government, which oversees funding for the Department of the Treasury, the Executive Office of the President, and other government functions;Homeland Security, which oversees funding for the Department of Homeland Security;Interior, Environment, and Related Agencies, which oversees funding for the Department of the Interior, the EPA, the U.S. Forest Service, and a number of independent agencies;Labor, Health and Human Services, Education, and Related Agencies, which oversees funding for the Department of Education, the Department of Health and Human Services, the Department of Labor, and other agencies;Legislative Branch, which oversees funding for the House of Representatives (the Senate Legislative Branch oversees funding for the U.S. Senate), the U.S. Capitol, the Library of Congress, and other legislative branch functions;Military Construction, Veterans Affairs, and Related Agencies, which oversees funding for military construction (including military housing), the Department of Veterans Affairs, and related agencies;State, Foreign Operations, and Related Programs, which oversees funding for the U.S. State Department, USAID, and related programs;Transportation, Housing and Urban Development, and Related Agencies, which oversees funding for the Department of Transportation, HUD, and related agencies.

In this episode, Matthew Harinstein, MD, MBA, VP and Associate CMO at Northwell, discusses how AI tools, system integration, and strong organizational culture are improving clinical workflows, expanding access, and enhancing patient care across the growing Northwell Health network.

About this episode: Robotic telesurgery allows providers to conduct minimally invasive surgeries across long distances, reaching remote communities. In this episode: Binita Ashar, a surgeon with a background in policy, discusses the revolutionary role this technology can play in medicine and what issues need to be addressed—from cost to cybersecurity—in order to greenlight more procedures in the United States. Guests: Binita Ashar, MD, MBA, is a general surgeon who previously served as the Director of the FDA's Office of Surgical and Infection Control Devices. She also serves on the board of the Society of Robotic Surgery. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs. Show links and related content: Exclusive look at groundbreaking remote robotic surgery: Patient was in Africa; doctor was in Florida—ABC News WHO and Society of Robotic Surgery launch health innovation initiative to expand access to virtual care and telesurgery—WHO Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.